Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]

IF 3.7 3区医学 Q1 HEMATOLOGY

Thrombosis research Pub Date : 2024-10-25 DOI:10.1016/j.thromres.2024.109198

Kui Liu , Zhen Hao , Hao Zheng , Haojie Wang , Luying Zhang , Minghui Yan , Reyisha Tuerhong , Yuling Zhou , Yan Wang , Tao Pang , Lei Shi

引用次数: 0

查看原文本刊更多论文

针对 c-Src 活性自磷酸化的利匹韦林预防血小板 β3 整合素依赖性血栓形成的再利用"[《血栓病研究》第 229 (2023) 53-68 页]的更正。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Thrombosis research 医学-外周血管病

CiteScore

14.60

自引率

4.00%

发文量

364

审稿时长

31 days

期刊介绍： Thrombosis Research is an international journal dedicated to the swift dissemination of new information on thrombosis, hemostasis, and vascular biology, aimed at advancing both science and clinical care. The journal publishes peer-reviewed original research, reviews, editorials, opinions, and critiques, covering both basic and clinical studies. Priority is given to research that promises novel approaches in the diagnosis, therapy, prognosis, and prevention of thrombotic and hemorrhagic diseases.